Literature DB >> 24614334

Autophagic effect of programmed cell death 5 (PDCD5) after focal cerebral ischemic reperfusion injury in rats.

Zhao Jiang1, Chun-Hua Chen1, Ying-Yu Chen2, Jing-Yan Han3, John Riley4, Chang-Man Zhou5.   

Abstract

Former studies indicated that programmed cell death 5 (PDCD5) protein could accelerate the process of apoptosis in response to some stimuli in various kinds of cells via the intrinsic or extrinsic pathway. In this study, we aimed to demonstrate for the first time that protein level of PDCD5 are related to autophagic activity after focal ischemic brain injury in rats. One hundred and twenty-five Sprague-Dawley rats (male) were randomly divided into the following groups: Sham operated, Middle Cerebral Artery Occlusion/Reperfusion (MCAO), MCAO+Control siRNA and MCAO+PDCD5 siRNA. Outcome measurements include neurobehavioral outcomes, brain infarct volume, brain water content, BBB disruption, MRI and double fluorescence labeling. Western blot and histopathophysiological techniques were used to measure the expression of PDCD5 and some pro-autophagic proteins such as Beclin 1 and the LC3-II/LC3-I ratio. The study found that decreased PDCD5 expression via intracerebroventricular injection of PDCD5 siRNA significantly improved the neurobehavioral outcome, reduced the infarct ratio, cerebral edema and BBB disruption. These results were associated with decreased expression of Beclin 1 and the LC3-II/LC3-I ratio in the penumbra area. Rapamycin, an inducer of autophagy, partially weakened the effect of PDCD5 siRNA. In conclusion, this study suggested that PDCD5 was a key regulator of autophagy that might play an important role following MCAO injury.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Autophagy; MCAO; MRI; PDCD5; siRNA

Mesh:

Substances:

Year:  2014        PMID: 24614334     DOI: 10.1016/j.neulet.2014.02.066

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Effects of CD25siRNA gene transfer on high-risk rat corneal graft rejection.

Authors:  Qin Qin; Yunjie Shi; Qingqing Zhao; Dan Luo; Yuan Chen; Jing Wu; Min Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-31       Impact factor: 3.117

2.  Programmed cell death 5 suppresses AKT-mediated cytoprotection of endothelium.

Authors:  Seung-Hyun Lee; Jaesung Seo; Soo-Yeon Park; Mi-Hyeon Jeong; Hyo-Kyoung Choi; Chan Joo Lee; Mi Jeong Kim; Garam Guk; SooYeon Lee; Hyewon Park; Jae-Wook Jeong; Chang Hoon Ha; Sungha Park; Ho-Geun Yoon
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-27       Impact factor: 11.205

3.  A quantitative MRI method for imaging blood-brain barrier leakage in experimental traumatic brain injury.

Authors:  Wei Li; Justin Alexander Long; Lora Talley Watts; Zhao Jiang; Qiang Shen; Yunxia Li; Timothy Q Duong
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

4.  Dynamic changes in neuronal autophagy and apoptosis in the ischemic penumbra following permanent ischemic stroke.

Authors:  Yi-Hao Deng; Hong-Yun He; Li-Qiang Yang; Peng-Yue Zhang
Journal:  Neural Regen Res       Date:  2016-07       Impact factor: 5.135

5.  Plasma MicroRNA-16 Is a Biomarker for Diagnosis, Stratification, and Prognosis of Hyperacute Cerebral Infarction.

Authors:  Chunou Tian; Zifu Li; Zhigang Yang; Qinghai Huang; Jianmin Liu; Bo Hong
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

6.  Deletion of Pdcd5 in mice led to the deficiency of placenta development and embryonic lethality.

Authors:  Ge Li; Chentong Xu; Xin Lin; Liujing Qu; Dan Xia; Beiqi Hongdu; Yan Xia; Xiaokun Wang; Yaxin Lou; Qihua He; Dalong Ma; Yingyu Chen
Journal:  Cell Death Dis       Date:  2017-05-25       Impact factor: 8.469

7.  MicroRNA-7, synergizes with RORα, negatively controls the pathology of brain tissue inflammation.

Authors:  Dongxu Yue; Juanjuan Zhao; Huizi Chen; Mengmeng Guo; Chao Chen; Ya Zhou; Lin Xu
Journal:  J Neuroinflammation       Date:  2020-01-20       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.